Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management
Mrinal M. Patnaik, Ayalew Tefferi
American Journal of Hematology (2024) Vol. 99, Iss. 6, pp. 1142-1165
Open Access | Times Cited: 23

Showing 23 citing articles:

Epigenetics-targeted drugs: current paradigms and future challenges
Wanlin Dai, Xinbo Qiao, Yuanyuan Fang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 19
Multi-omic analysis of chronic myelomonocytic leukemia monocytes reveals metabolic and immune dysregulation leading to altered macrophage polarization
Hasse M. Addinsell, Rachel Cant, Nathan J. Hull, et al.
Leukemia (2025)
Open Access
Comprehensive analysis of clinical, pathological, and molecular features in chronic myelomonocytic leukemia: frequent ASXL1 and NRAS mutations and higher mutation burden in myeloproliferative CMML compared to myelodysplastic CMML
Dajeong Jeong
Leukemia & lymphoma/Leukemia and lymphoma (2025), pp. 1-10
Closed Access
Myeloid-Derived Suppressor Cells: Implications in Cancer Immunology and Immunotherapy
Juan F. Santibáñez
Frontiers in Bioscience-Landmark (2025) Vol. 30, Iss. 3
Open Access
5-FU@HFn combined with decitabine induces pyroptosis and enhances antitumor immunotherapy for chronic myeloid leukemia
Zuowei Yuan, Guoyun Jiang, Ying Yuan, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Chronic Myelomonocytic Leukemia and Atypical Chronic Myeloid Leukemia: A National Analysis
Victoria A. Vardell, Jennifer Ose, Anton Rets, et al.
Clinical Lymphoma Myeloma & Leukemia (2024) Vol. 24, Iss. 12, pp. 843-851
Closed Access | Times Cited: 2
PHF6 mutations in chronic myelomonocytic leukemia identify a unique subset of patients with distinct phenotype and superior prognosis
Ayalew Tefferi, Saubia Fathima, Ali Alsugair, et al.
American Journal of Hematology (2024)
Open Access | Times Cited: 2
Targeting pivotal amino acids metabolism for treatment of leukemia
Jiankun Hong, Wuling Liu, Xiao Xiao, et al.
Heliyon (2024) Vol. 10, Iss. 23, pp. e40492-e40492
Open Access | Times Cited: 2
scPharm: Identifying Pharmacological Subpopulations of Single Cells for Precision Medicine in Cancers
Peng Tian, Jie Zheng, Keying Qiao, et al.
Advanced Science (2024) Vol. 12, Iss. 2
Open Access | Times Cited: 1
Leukemic retinopathy, the first expression in a case of chronic myelomonocytic leukemia - a case report
Marina Istrate, Andreea Ciubotaru, Mihai Hasbei-Popa, et al.
Romanian Journal of Ophthalmology (2020) Vol. 64, Iss. 4, pp. 419-422
Open Access | Times Cited: 4
Pivotal Amino Acids Metabolism in the Progression of Leukemia
Jiankun Hong, Wuling Liu, Xiao Xiao, et al.
(2024)
Closed Access
Does Sustained Monocytosis Always Mean CMML? A Case of Ras-Associated Autoimmune Leukoproliferative Disorder
David R. Rodriguez, Gabriela Luque, Maria Belen Fiora, et al.
The Hematologist (2024) Vol. 21, Iss. 6
Open Access
Prognostic Significance and Treatment Response Associations of Genetic Mutations in Chronic Myelomonocytic Leukemia: A Retrospective Cohort Study
Jing Di, Leonard N. Yenwongfai, Talal Arshad, et al.
Biomedicines (2024) Vol. 12, Iss. 11, pp. 2476-2476
Open Access
Diagnostic Challenges and Criteria Application in a 70-Year-Old Patient with Oligo Monocytic Chronic Granulomonocytic Leukemia: A Case Report
Xiaomei Wang, Tao Chen
Leukemia Research (2024) Vol. 147, pp. 107616-107616
Closed Access
Chronic myelomonocytic leukemia primarily presenting as life‐threatening pericardial effusion, Eldoret, Kenya: A case report
Victor M. Wauye, Evangeline Njiru, Angela K. Amadi, et al.
Clinical Case Reports (2024) Vol. 12, Iss. 6
Open Access
Single cell multiomic analyses reveal divergent effects of DNMT3A and TET2 mutant clonal hematopoiesis in inflammatory response
Wazim Mohammed Ismail, Jenna Fernandez, Moritz Binder, et al.
Research Square (Research Square) (2024)
Open Access
Prognostic and therapeutic implications of TP53 expression in chronic myelomonocytic leukemia
Yu‐Hung Wang, Chien‐Chin Lin, Kristian Gurashi, et al.
Blood Cancer Journal (2024) Vol. 14, Iss. 1
Open Access
Clonal Monocytosis of Renal Significance
Anuya A. Natu, Ishan Gupta, Nelson Leung, et al.
Kidney International (2024)
Closed Access
Clinical value of smear review of flagged samples analyzed with the Sysmex XN hematology analyzer
Anne Winther‐Larsen, Else Marie Vestergaard, Anders Abildgaard
Clinical Chemistry and Laboratory Medicine (CCLM) (2024)
Closed Access
Decoding the Immune Microenvironment of Secondary Chronic Myelomonocytic Leukemia due to DLBCL with CD19 CAR-T Failure by Single-cell RNA-seq
Xudong Li, Hong Huang, Jianxiang Shi, et al.
(2024)
Closed Access
Survival Outcomes of U.S. Patients with CMML: A Two-Decade Analysis from the SEER Database
Ayrton Bangolo, Behzad Amoozgar, Abhishek Thapa, et al.
Medical Sciences (2024) Vol. 12, Iss. 4, pp. 60-60
Open Access
Síndromes mielodisplásicos y leucemia mielomonocítica crónica
Marta Callejas Charavía, G. López de Hontanar Torres, G. Motornaya Morozova, et al.
Medicine - Programa de Formación Médica Continuada Acreditado (2024) Vol. 14, Iss. 20, pp. 1171-1182
Closed Access
Enhancer deregulation in TET2 Mutant Clonal Hematopoiesis is associated with increased COVID-19 related inflammation severity and mortality
Wazim Mohammed Ismail, Jenna Fernandez, Moritz Binder, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Page 1

Scroll to top